Fagron (XAMS:FAGR) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XAMS:FAGR Fagron SA XAMS:FAGR
90 GF Score
Price €6.42
GF Value €6.47
! 6 Warning Signs
View Full Analysis

What is Fagron Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XAMS:FAGR
90GF Score
Fagron SA XAMS:FAGR
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fagron (XAMS:FAGR) Overvalued in 2026?

Based on GuruFocus' analysis, Fagron stock appears to be undervalued. The current stock price of €6.42 is trading 0.8% below its estimated GF Value™ of €6.47.

Key valuation signals for XAMS:FAGR:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €6.47 vs. price of €6.42 (0.8% below fair value)
  • GF Score™: 90/100 with 6 warning signs

No single metric tells the full story. See the XAMS:FAGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fagron Business Description

Address Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
90GF Score

Get the complete analysis for XAMS:FAGR

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.42
Price
€6.47
GF Value